FindTrial
Sign In

Effects of Preoperative Nefopam Dosage on the frequency and Severity of Catheter-Related Bladder Discomfort After Ureteroscopic litholapaxy

Effects of Preoperative Nefopam Dosage on the frequency and Severity of Catheter-Related Bladder Discomfort After Ureteroscopic litholapaxy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008381
Enrollment
102
Registered
2023-04-25
Start date
2023-04-05
Completion date
Unknown
Last updated
2023-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Myongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult men and women aged 19 years or older who underwent ureteroscopic lithotripsy

Exclusion criteria

Exclusion criteria: - bladder outflow obstruction and overactive bladder ( frequency > 3 time / night , 8 time / 24hr ) - epilepsy , myocardial infarction , arrhythmia , heart failure - renal and hepatic disease, current use of monoamine oxidase inhibitor - Hx of drugs , alcohol abuse , angle-closure glaucoma - morbid obesity - hx of chronic pain, and a history of psychiatric condition

Design outcomes

Primary

MeasureTime frame
CRBD severity, pain—

Secondary

MeasureTime frame
Age, gender, height, weight, underlying disease, stone location, size of stone, anesthesia record, surgical record—

Countries

Korea, Republic of

Contacts

Public ContactHyung Rae Cho

Myongji Hospital

callmex@hanmail.net+82-31-810-5114

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026